Permanent methods are the most commonly used contraceptive options worldwide. Even with the increase in popularity and accessibility of long-acting reversible methods, there remains high demand for permanent options, especially among women in developing countries.
INTRODUCTION
Surgical permanent methods are the most commonly used forms of contraception worldwide, with the prevalence in developing countries averaging 20.6% and exceeding 35% in countries such as India, Colombia, and El Salvador [1, 2] . In the United States, female surgical permanent contraception is the most common method used in women over the age of 35 [1] . Although the total annual number of permanent contraception procedures in the United States has declined slightly, from 687 000 in 1995 to 643 000 in 2006 [3] , tubal ligation or occlusion is the fifth most frequently performed surgical procedure, following cesarean section, abortion, cholecystectomy, and coronary angioplasty [3] [4] [5] . The wider availability and acceptance of long-acting reversible methods likely explains the decrease in procedures.
Tubal ligation or occlusion has traditionally been referred to as female sterilization. However, in some settings, the term 'sterilization' can imply an involuntary or coercive process. Instead, the term 'permanent contraception' offers an alternative to recognize a woman's active and informed decision to complete childbearing [6] . Indeed, women today have many permanent contraception options to choose from including postpartum tubal ligation, interval surgical tubal ligation, and hysteroscopic tubal occlusion, and new methods of nonsurgical permanent contraception are currently under development. The present article reviews each of these methods, their risks and benefits, and potential alternatives that may soon be available to women.
POSTPARTUM TUBAL LIGATION
In the United States, postpartum tubal ligations are performed after 8-9% of all deliveries and represent approximately half of all permanent contraception procedures [3] . Postpartum, permanent contraception is commonly approached by minilaparotomy, often at the level of the umbilicus, or at the time of cesarean section using a modified Pomeroy or Parkland partial salpingectomy technique [7] . These well tolerated, simple procedures ligate and remove a mid-isthmic segment of the fallopian tube bilaterally [8] . The partial salpingectomy failure rate is approximately 0.6/1000 in 1 year and 7.5/1000 in 10 years [1, 9] . The 10-year probability of ectopic pregnancy is lowest for postpartum partial salpingectomy compared with other interval techniques, at 1.5 per 1000 [10] . Complications are rare and mostly related to the risks of the pregnancy, vaginal delivery, or cesarean section [1] . For women delivering vaginally, the procedure can be performed immediately, or anytime prior to hospital discharge.
Use of mechanical devices, such as titanium (Filshie) clips, are less commonly used postpartum. Contrary to their use as an interval technique, titanium clips have not been shown to have equivalent efficacy with partial salpingectomy in the immediate postpartum period. One retrospective cohort of 290 women undergoing permanent contraception at the time of cesarean section in the United Kingdom found no subsequent pregnancies in the partial salpingectomy group (0/203) over a median follow up of 9 years compared with one in the Filshie clip group over a median follow up of 8 years (1/87, 1.15%, P ¼ 0.3) [11] . Another randomized control trial of women electing postpartum permanent contraception after vaginal delivery found a significantly higher cumulative probability of pregnancy with use of the titanium clip (0.017) compared with partial salpingectomy (Pomeroy method; 0.004, P ¼ 0.04) over 24 months of follow up [12] . Although weaknesses of the two studies include small sample sizes and high loss-to-follow-up proportions, a subsequent systematic review recommended against routine use of the titanium clip for postpartum permanent contraception because of concern for decreased efficacy compared with partial salpingectomy [13] .
INTERVAL LAPAROSCOPIC TUBAL LIGATION AND OCCLUSION
Surgical permanent contraception procedures occuring outside the postpartum period, or in women who have never been pregnant, are considered 'interval' in timing. Although interval permanent contraception via minilaparotomy remains common in many low resource areas, interval procedures are typically done laparoscopically in a daypatient operating room setting. Methods include electrocoagulation, mechanical occlusion with slicone rubber bands, spring clips or titantium clips, and partial or total salpingectomy. The U.S. Collaborative Review of Sterilization followed over 10 000 women for 8-14 years after undergoing various methods of permanent contraception and found the 10-year cumulative probability of pregnancy with interval methods to be highest after spring clip procedures (36.5/1000 procedures) and lowest after unipolar coagulation (7.5/1000 procedures). The cumulative probability of pregnancy was highest in the youngest cohort of women who underwent procedures between ages 18 and 27 years [9] . Of note, this large prospective cohort did not include titanium clips, which were not introduced onto the U.S. market until 1996, and also took place at several centers where there was less experience with some of the newer procedures than the older ones.
A recent large population-based retrospective study evaluated ectopic pregnancy risk in a cohort of 44 829 women in Western Australia followed for up to 20 years after a variety of interval permanent contraception procedures [14 & ]. Five methods of laparoscopic permanent contraception were compared, including titanium clips, partial salpingectomy, total salpingectomy, electrocautery, and unspecified destruction/occlusion of the fallopian tubes. Compared with the reference group of laparoscopic unspecified destruction of the tube [ 
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aHR ¼ 1.19 (0.68-2.06)] and laparoscopic salpingectomy (0/195, aHR ¼ 0) were not significantly different. For women undergoing permanent contraception at younger than age 28, the 10-year cumulative probability of ectopic pregnancy was 3.5 times that of women undergoing permanent contraception after age 33. In addition to being very effective, laparoscopic permanent contraception procedures are well tolerated. Rare but serious complications of unipolar cautery, which was associated with thermal bowel injury, led to the development of alternative techniques [15] . The overall risk of complication associated with laparoscopic band, clip, and bipolar cautery alternatives is very low, estimated at 0.9-1.6 per 100 procedures [15, 16] . Rare serious complications include unplanned major surgery required because of an intraoperative complication, blood transfusion, infection, a life-threatening event, or hospital readmission [17] . Prior abdominal or pelvic surgery, obesity, diabetes, and general anesthesia are independent risk factors for complications [16] .
General anesthesia is commonly used with laparoscopy in the United States, and women may experience postoperative pain from carbon dioxide-related intraperitoneal irritation, necrosis of the fallopian tubes at the occlusion or cauterization site, or stretching of nerves. A meta-analysis of randomized, double-blind placebo-controlled trials evaluating topical application of local anesthetic during laparoscopic ring or clip procedures confirmed a benefit in patient-reported pain scores up to 8 h postoperatively [18 & ]. This minimal intervention can help make an already simple, effective, lowrisk procedure even more tolerable to the patient.
The total salpingectomy alternative
Although laparoscopic occlusion and cautery methods have become the interval permanent contraception procedures of choice for many hospitals and clinicians, there is increasing discussion about the role salpingectomy should play as an ovarian cancer risk-reducing measure for women interested in permanent contraception. There is evidence to support the hypothesis that epithelial ovarian cancers may originate from the fallopian tube [19] [20] [21] [22] . Given these data, there has been a recent call for surgeons to consider performing a salpingectomy at the time of other benign surgeries (such as hysterectomy) for ovarian cancer risk reduction, and performing a salpingectomy in place of a tubal ligation for ovarian cancer risk reduction [23, 24] . A large retrospective study examined Ob/Gyn practices after a Canadian regional education campaign about the likely link between ovarian cancer and the fallopian tubes [25 && ]. This study found an increase in salpingectomy with hysterectomy and with interval and postpartum tubal ligation. For instance, only 0.3-0.4% of tubal permanent contraception procedures were salpingectomies in the 2 years leading up to the intervention, but salpingectomies increased to 11.4 and 33.3% in the subsequent 2 years, respectively. They also demonstrated the operative time increased by 10 min with salpingectomy compared with an occlusive method, and there were no statistically significant differences in complications. A recent Canadian cost-effectiveness analysis found that although salpingectomy for sterilization is slightly more expensive than tubal ligation (CAD $9720 AE 3.74 compared with $9339 AE 26.74), it is a more effective procedure with a cost-effectiveness ratio of $27 278/year of life gained [26 & ]. The model found salpingectomy to provide a 29.2% ovarian cancer risk reduction compared with standard tubal ligation. Furthermore, these authors concluded that salpingectomy would have to be $1000 more expensive to lose cost-effectiveness. Although the potential ovarian cancer riskreducing benefits of salpingectomy are impressive, there is also the potential benefit of salpingectomy's near 100% efficacy as a permanent contraception method [23] . However, we do not yet have prospectively collected data on long-term outcomes regarding surgical complication rates, failure rates, ectopic pregnancies, or ovarian cancer risk reduction. In addition, there is also evidence to support that tubal ligation/occlusion decreases the risk of epithelial ovarian cancer independent of salpingectomy [27,28 & ,29]. For example, population-based casecontrol studies indicate that women with ovarian cancer are 30% less likely to have had a tubal ligation [29, 30] . Thus, the American Congress of Obstetricians and Gynecologists (ACOG) recommends that 'randomized controlled trials are needed to support the validity of salpingectomy to reduce the incidence of ovarian cancer. The approach to hysterectomy or sterilization should not be influenced by the theoretical benefit of salpingectomy. Surgeons should continue to observe and practice minimally invasive techniques' [31] .
HYSTEROSCOPIC TUBAL OCCLUSION
Another alternative interval permanent contraception method is hysteroscopic tubal occlusion. This has become an increasingly popular option since the introduction of Essure in the U.S. in November 2002 [32] . The Essure device consists of a nickel-titanium alloy outer coil and a stainless-steel inner coil wrapped in polyethylene terephthalate fibers. A disposable introducer is used to position the wound-coil insert into proximal portion of each fallopian tube under hysteroscopic or fluoroscopic guidance [1] . A significant benefit of this technique is that it can be done in a clinic setting with only local paracervical anesthetic [33] . In addition to reducing cost, this technique reduces the risks associated with general anesthesia and intra-peritoneal surgery [17] . However, both the manufacturer and the FDA recommend a hysterosalpingogram (HSG) 3 months postprocedure to confirm bilateral tubal occlusion and an alternative method of contraception during the interim [34] . This confirmatory HSG requires radiation exposure, a skilled professional to perform and interpret the test, and may require the patient to travel a significant distance to the nearest radiology center, all of which add significant clinical and opportunity costs to the procedure. Together, these burdens commonly result in high proporations of women (6-87%) who do not complete the confirmatory HSG [35 && ]. As verification of correct placement and tubal occlusion with HSG were required parts of the Essure clinical trials, efficacy should not be assumed in the absence of this step. Women should be counseled about the importance of the confirmatory HSG, and if it is too burdensome or inconvenient, should preferentially be counseled about methods with more immediate efficacy.
Another important counseling topic is the potential inability to successfully place coils bilaterally. The phase II trial for the Essure device demonstrated 200/227 (88%) successful bilateral coil placement at the time of procedure [36] . Of these women, 191/200 (96%) had satisfactory device location and bilateral tubal occlusion. An additional seven women (198/200, 99%), demonstrated bilateral tubal occlusion at 6 months postprocedure. Other studies have demonstrated a range of 76-96% successful bilateral coil placement on initial attempt, with 5-16% of HSGs failing to show bilateral tubal occluson at 3 months post-Essure [35 && ]. This can leave women at risk of unintended pregnancy. A systematic review exploring pregnancy after hysteroscopic permanent contraception found that in 22 articles there were 102 reported pregnancies after Essure placement, 18 of which occurred prior to the confirmatory HSG [37] . However, most studies included had less than 5 years of follow-up, making long-term pregnancy risks difficult to evaluate. In a retrospective review of the Essure manufacturer's commercially available data from 2001 to 2010, 748 (0.15%) pregnancies were reported out of 497 305 distributed Essure kits [38 & ]. Although helpful, this reporting system may underestimate the true number of pregnancies that occur after hysteroscopic permanent contraception. Gariepy et al. ]. Other complications include malposition or expulsion of the coils, which may necessitate removal and replacement or use of an alternative permanent contraception method. Chronic pain has been associated with malposition or perforation, but should resolve with removal of the coils [39 & ]. However, some women will report an increase in dysmenorrhea and pelvic symptoms as they transition from hormonal contraception to the nonhormonal Essure. Although hysteroscopic and laparoscopic removal is technically feasible, hysterectomy may be preferable to completely remove the coils.
Women with nickel hypersensitivities should be counseled that the reported incidence of sensitivity to the Essure coils is very low (0.01%) [17] . Screening patch tests for nickel sensitivity are not cost-effective, but could be considered in women who have significant preprocedure concern for allergy or postprocedure symptoms [17,39 & ]. Overall, hysteroscopic permanent contraception is a well tolerated and effective alternative method of interval permanent contraception.
NEW METHODS OF PERMANENT CONTRACEPTION
Given the high demand for permanent contraception by women around the world, developing new methods of permanent contraception could help improve women's access and potentially decrease associated risks and costs. For example, hysteroscopic permanent contraception methods that are immediately effective and do not require back-up contraception nor a confirmatory HSG are being explored [40,41 & ]. An immediately effective but potentially reversible hysteroscopically placed insert is also under development in China [42 & ]. A major challenge in developing a reversible system is that epithelial destruction and collagen deposition in the transmural segment are required for effective contraception [43] . Devices that occupy but do not damage the tube typically undergo explusion or the tube will dilate and allow passage of gametes.
Although improvements in hysteroscopic permanent contraception options certainly are warranted, the cost and availability of hysteroscopic equipment may still preclude availability of these methods in low-resource settings. Nonsurgical permanent contraception (NSPC) methods may offer a solution for these women, and a more convenient and lower cost option for women in more developed regions. Chemically induced tubal occlusion has been previously investigated, most notably with quinacrine [44] [45] [46] . However, need for repeated treatments, high failure rates, and concern for potential toxicity led to alternative developments. Currently, transcervical polidocanol foam (a sclerosing agent) is under investigation in nonhuman primates with promising initial findings [47,48 && ]. When women's and provider's perceptions of NSPC were explored, the need for long-term safety and efficacy data were expressed and the desire for confirmation of successful tubal occlusion [49 & ]. Alternative confirmatory tests to HSG are needed to reduce cost and radiation exposure and to improve convenience and accessibility for women. Measurement of intrauterine pressure after NSPC is a potential option under preliminary investigation [50 & ]. Novel developments in NSPC and confirmation of tubal occlusion have the potential to greatly improve the acceptability and availability of permanent contraception methods.
BARRIERS TO ACCESSING PERMANENT CONTRACEPTION
The tragic deaths of 16 women who underwent laparoscopic tubal ligation in Bilaspur, India, in November 2014, reinforce the persistent need for well tolerated and effective methods of permanent contraception [51] . Women's health providers and advocates should continue to find ways to remove barriers to current methods of permanent contraception while maintaining an excellent quality of care. Strategies could include expansion of provider-types offering permanent contraception methods [52 & ,53]. NSPC methods would likely be very amenable to provision by healthcare workers in low-resource settings. In the United States, unintended pregnancies could be reduced and public money saved by modifying existing Medicare laws that require waiting periods prior to permanent contraception and prohibit women from undergoing permanent contraception at the time of abortion [54,55 && ,56].
CONCLUSION
Overall, permanent contraception methods continue to be highly desired by women and are generally well tolerated and effective. Immediately effective hysteroscopic and nonsurgical permanent contraception methods would add to the complement of currently available methods and increase access to permanent contraception. Finally, further funding for the research and development of novel permanent contraception methods will help ensure women in future generations have access to the contraceptive method of their choosing.
